AMPH - Wutah bathi EPS kuartalan Amphastar Pharmaceuticals, Inc.

Quarterly earnings per share dynamics confirm the success of Amphastar Pharmaceuticals (AMPH) in developing high-tech injectables that create stringent barriers to entry for competitors. The value of 138.60 expresses the current value of the metric. Growth is driven by the monopoly pricing power of scarce medications with inelastic demand. Financial stability is supported by excess liquidity and a steady cash flow generated by high operating profitability.

This metric measures the percentage change in net income per share compared to the same quarter of the previous year. GURU.Markets tools visualize this quarterly earnings per share (EPS) growth to track business scaling rates. The line's dynamics depend directly on the efficiency of operating expense and revenue management. For Amphastar Pharmaceuticals (AMPH), such volatility reflects the margins of producing complex injectable drugs. Steady growth of this indicator confirms the competitive advantages of a vertically integrated model within the rare generics segment.